Target intelligence / Profile preview

Decorin-binding receptors and partners (DCN-BRP)

Target
DCN-BRP
Molecular classification
Receptor tyrosine kinase, Proteoglycan-binding protein, Extracellular matrix protein, Toll-like receptor, Integrin
01

Overview

Decorin-binding receptors and partners comprise a diverse array of cell surface signaling molecules and extracellular matrix (ECM) components that interact with the small leucine-rich proteoglycan (SLRP) decorin. This interactome is primarily defined by decorin's role as a "pan-receptor tyrosine kinase (RTK) inhibitor," where it binds to and antagonizes key receptors such as the epidermal growth factor receptor (EGFR), hepatocyte growth factor receptor (Met), and vascular endothelial growth factor receptor 2 (VEGFR2) [1.3.1, 1.5.1]. Upon binding, decorin triggers receptor dimerization, internalization via caveolae, and subsequent lysosomal degradation, thereby suppressing oncogenic signaling pathways [1.3.4, 1.5.1]. Furthermore, decorin acts as a biological reservoir or "sink" for various growth factors, most notably transforming growth factor-beta (TGF-beta), which allows it to modulate fibrotic responses and immune signaling [1.2.1, 1.3.4]. In the tumor microenvironment, these interactions collectively inhibit cell proliferation, angiogenesis, and metastasis while promoting tumor cell mitophagy and endothelial cell autophagy [1.1.3, 1.2.3]. Therapeutic strategies targeting this network include recombinant human decorin and targeted fusion proteins like CAR-decorin, which are being investigated for their potential to treat solid tumors and chronic fibrotic conditions [1.1.3, 1.2.1]. However, the broad nature of these interactions presents challenges, including potential pro-inflammatory effects through Toll-like receptors (TLR2/4) and the risk of interfering with normal tissue repair and growth factor homeostasis [1.2.2, 1.4.1].

Other names
Decorin interactomeDecorin-binding partnersPan-receptor tyrosine kinase inhibitor targetsDCN-binding receptorsDecorin-binding proteins
02

Mechanism of action

Competitive inhibition of growth factor binding, induction of receptor internalization and degradation, sequestration of growth factors (e.g., TGF-beta), and induction of Peg3-dependent autophagy.

03

Biological functions

Signal transductionAutophagyAngiogenesis inhibitionCollagen fibrillogenesisCell cycle regulationApoptosisImmune responseExtracellular matrix organization
04

Disease associations

CancerFibrosisInflammationCardiovascular diseaseMuscular dystrophyWound healing
05

Safety considerations

Potential for systemic inflammation via TLR2/4 activationImpaired wound healing due to TGF-beta inhibitionOff-target inhibition of essential growth signaling in healthy tissuesPotential for altered collagen fibrillogenesis and tissue fragility
06

Interacting drugs

Recombinant human decorin

3 more in the full profile.

07

Biomarkers

Serum decorin (DCN) levelsEpidermal growth factor receptor (EGFR) expressionHepatocyte growth factor receptor (Met) expressionTransforming growth factor-beta (TGF-beta) levels

Beyond the preview

Go deeper on Decorin-binding receptors and partners (DCN-BRP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Decorin-binding receptors and partners (DCN-BRP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call